KALA BIO, INC.
Profile
Company Names
KALA BIO, INC.
KALA PHARMACEUTICALS, INC.
Addresses
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA 02476
490 ARSENAL WAY, SUITE 120, WATERTOWN, MA 02472
100 BEAVER STREET, SUITE 201, WALTHAM, MA 02453
135 BEAVER STREET, SUITE 309, WALTHAM, MA 02452
135 BEAVER STREET, #309, WALTHAM, MA 02452
MINTZ LEVIN COHN FERRIS GLOVSKY + POPEO, ONE FINANCIAL CENTER, BOSTON, MA 02111
Phone Numbers
781-996-5252
(781) 996-5252
617-542-2241
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS, BIOTECHNOLOGY
Year Incorporated:
2009
State Incorporated:
DELAWARE
Total Amount Raised:
$158,790,560.00
Number of Funding Rounds:
12
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
12
2026-03-03
$1,753,500.00
$1,753,500.00
$0.00
Equity
11
2026-01-30
$2,250,600.00
$4,200,000.00
$1,949,400.00
Equity
10
2024-12-31
$10,749,667.00
$10,749,667.00
$0.00
Equity
9
2024-06-28
$12,499,192.00
$12,499,192.00
$0.00
Equity
8
2021-11-15
$16,122,541.00
$36,522,541.00
$20,400,000.00
Equity
7
2016-04-06
$67,921,796.00
$67,921,796.00
$0.00
Equity
6
2015-08-17
$6,999,999.00
$6,999,999.00
$0.00
Equity
5
2014-04-16
$22,500,000.00
$22,500,000.00
$0.00
Equity
4
2013-02-14
$5,750,059.00
$11,500,118.00
$5,750,059.00
Equity
3
2012-02-29
$7,243,205.00
$7,243,205.00
$0.00
Equity
2
2010-10-26
$3,000,000.00
$3,000,000.00
$0.00
Equity, Debt
1
2009-12-11
$2,000,001.00
$2,000,001.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
KEVIN
BITTERMAN
DIRECTOR
PARASOL THERAPEUTICS INC
| TARIS BIOMEDICAL INC
| BIOLEX THERAPEUTICS, INC.
| FOLLICA, INC
| VISTERRA, INC.
| KALA PHARMACEUTICALS, INC.
| GENOCEA BIOSCIENCES, INC.
| NEURONETICS, INC.
| DIRECT VET MARKETING, INC.
| EDITAS MEDICINE, INC.
| MORPHIC HOLDING, LLC
| ATLAS VENTURE FUND XI, L.P.
| NAVITOR PHARMACEUTICALS, INC.
| AKERO THERAPEUTICS, INC.
| ATLAS VENTURE OPPORTUNITY FUND I, L.P.
| ATLAS VENTURE FUND XII, L.P.
| KINASET THERAPEUTICS, INC.
| ATLAS VENTURE OPPORTUNITY FUND II, L.P.
| ATLAS VENTURE FUND XIII, L.P.
| JUDO BIO INC.
| CHROMA MEDICINE, INC.
| REMIX THERAPEUTICS, INC.
| GRO BIOSCIENCES INC.
| ATLAS VENTURE FUND XIV, L.P.
| RENASANT BIO, INC.
| ATLAS VENTURE OPPORTUNITY FUND ILL, L.P.
MARK
S.
BLUMENKRANZ
DIRECTOR
PETER
COUROSSI
EXECUTIVE OFFICER
ANDREA
FRANZ
EXECUTIVE OFFICER
GREG
GRUNBERG
DIRECTOR
JUSTIN
HANES
DIRECTOR
MARK
IWICKI
EXECUTIVE OFFICER, DIRECTOR
ANDREW
I.
KOVEN
DIRECTOR
ROBERT
LANGER
DIRECTOR
MICROCHIPS, INC.
| ARSENAL MEDICAL, INC.
| ALSERES PHARMACEUTICALS INC /DE
| ECHO THERAPEUTICS, INC.
| MICELL TECHNOLOGIES INC
| CERULEAN PHARMA INC.
| HUMACYTE INC
| COMBINENT BIOMEDICAL SYSTEMS, INC.
| TARIS BIOMEDICAL INC
| KALA PHARMACEUTICALS, INC.
| FIBROCELL SCIENCE, INC.
| PREDICTIVE BIOSCIENCES, INC
| SEVENTH SENSE BIOSYSTEMS, INC.
| T2 BIOSYSTEMS, INC.
| SEMPRUS BIOSCIENCES CORP
| LIQUIDX, INC.
| ARSENAL VASCULAR, INC.
| ARSENAL MEDICAL, INC.
| SELECTA BIOSCIENCES INC
| STEMNION, INC.
| 480 BIOMEDICAL, INC.
| LIVING PROOF INC
| DX BIOSCIENCES, INC.
| MODERNA LLC
| HUMACYTE, INC
| XTUIT PHARMACEUTICALS, INC.
| SQZ BIOTECHNOLOGIES CO
| NOVEOME BIOTHERAPEUTICS, INC.
| LYNDRA, INC.
| MODERNA THERAPEUTICS, INC.
| VERSEAU THERAPEUTICS, INC.
| FREQUENCY THERAPEUTICS, INC.
| SUONO BIO, INC.
| COMBINED THERAPEUTICS, INC.
| HUMACYTE, INC.
| SEER BIOSCIENCES, INC.
| LANDSDOWNE LABS, LLC
| LIKEMINDS, INC./DE
| TARVEDA THERAPEUTICS, INC.
| LUMINOPIA, INC.
| LYRA THERAPEUTICS, INC.
| ABPRO CORP
| GLYMPSE BIO, INC.
| EPIBONE, INC.
| TEAL BIO, INC.
| ZWI THERAPEUTICS, INC.
| LYNDRA THERAPEUTICS, INC.
| KENDALL CAPITAL PARTNERS I, L.P.
| BILAYER THERAPEUTICS, INC.
| XENTER, INC.
| VIVTEX CORP
| SYNTIS BIO, INC.
| OMNIPULSE BIOSCIENCES, INC.
DAVID
LAZAR
DIRECTOR
CHARLES
MCDERMOTT
EXECUTIVE OFFICER
ROBERT
PAULL
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
GREGORY
D.
PERRY
DIRECTOR
BRENDAN
PURDY
DIRECTOR
HOWARD
B.
ROSEN
DIRECTOR
RAJEEV
SHAH
DIRECTOR
CIVITAS THERAPEUTICS, INC.
| KALA PHARMACEUTICALS, INC.
| RA PHARMACEUTICALS, INC.
| SATSUMA PHARMACEUTICALS, INC.
| EIDOS THERAPEUTICS, INC.
| BLACK DIAMOND THERAPEUTICS, INC.
| RA CAPITAL HEALTHCARE FUND LP
| RA CAPITAL HEALTHCARE INTERNATIONAL FUND LTD
| SOLID BIOSCIENCES INC.
| RA CAPITAL NEXUS INTERNATIONAL FUND, L.P.
| RA CAPITAL NEXUS FUND, L.P.
| CELONA, INC.
| RA CAPITAL NEXUS INTERNATIONAL FUND III, L.P.
| RA CAPITAL NEXUS FUND III, L.P.
| ABCURO, INC.
| RA CAPITAL PLANETARY HEALTH FUND, L.P.
| RA CAPITAL PLANETARY HEALTH INTERNATIONAL FUND, L.P.
ROBERT
TEPPER
DIRECTOR
CERULEAN PHARMA INC.
| ALNARA PHARMACEUTICALS INC
| CONSTELLATION PHARMACEUTICALS INC
| FOUNDATION MEDICINE, INC.
| KALA PHARMACEUTICALS, INC.
| BLUEBIRD BIO, INC.
| THIRD ROCK VENTURES III, L.P.
| ALLENA PHARMACEUTICALS, INC.
| JOUNCE THERAPEUTICS, INC.
| THIRD ROCK VENTURES IV, L.P.
| NEON THERAPEUTICS, INC.
| THIRD ROCK VENTURES V, L.P.
| FAZE MEDICINES, INC.
| THIRD ROCK VENTURES VI, L.P.
ERIC
L.
TRACHTENBERG
EXECUTIVE OFFICER
CHEN
YU
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2026-03-03
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2026-01-30
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2024-12-31
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2024-06-28
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2021-11-15
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2016-04-06
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

